01/04/2024
Kate Middleton’s recent cancer diagnosis has highlighted the importance of early detection to us all. Detecting potential health issues early means individuals can work with healthcare professionals to implement treatment plans, lifestyle changes, or preventative measures. These could mitigate, or even prevent the progression of certain diseases.
An article published by the Daily Mail, which focuses on early cancer detection MOT’s, emphasises the importance of preventative testing and treatment throughout. Charlotte Griffiths, who underwent our Everywoman Plus Tumour-Associated Markers test, stated that it is vital to keep a watchful eye for any unexpected bodily changes, such as unexplained bumps or weight loss, which may indicate a presence of cancer.
At Randox Health, we test for a range of different tumour markers, as well as genetic testing, to deliver information on cancer risk to an individual. This aims to empower people to be proactive towards improving their health and makes them aware of any potential future health risks they may have.
It is estimated that 30-50% of all cancer cases are avoidable, and in many cases, early detection is key and can save lives. Cancer that s diagnosed at an early stage, when it isn’t too large and hasn’t spread, is more likely to be treated successfully.
Spotting cancer at an early stage can save lives, however many people do not have access to the information or services to facilitate this detection. Over 8 million people in the UK are currently awaiting diagnostic testing. At Randox Health, with over 40 years’ experience in working towards improving healthcare worldwide, we have a focus on preventative healthcare; aiming to achieve better health outcomes whilst reducing the burden on clinical services.
At Randox Health we offer genetic risk tests for inherited cancers, including Breast and Ovarian Cancer, Bowel Cancer, and others. In addition, we offer a range of full-body health tests that include common tumour-associated markers.
The results from your tests allow you to get a more accurate representation of your current health status, as well as giving you the ability to make lifestyle changes to potentially prevent future health risks.
Genetic Cancer Risk £750 – 1 in 10 cancers are thought to be caused by hereditary gene mutations. This test covers 94 different genes suspected to play a role in predisposing to cancer, including genes associated with increased risk of breast, ovarian, prostate, colorectal, and thyroid cancer. Our genetic counsellor will guide and support you throughout your test and will also be available to explain your results and advise on next steps.
Genetic Breast and Ovarian Cancer Risk £499 – Around 5-10% of breast cancers are thought to be hereditary and up to 20% of ovarian cancers are genetic. This test covers 8 different genes including BRCA1 and BRCA2, associated with both hereditary breast and ovarian cancer.
Genetic Bowel Cancer Risk £499 – It is estimated that 1 in 15 males and 1 in 8 females will develop bowel cancer in their lifetime, with around 5-10% of all bowel cancers thought to be caused by a mutation in a known gene. This test screens for mutations in 11 different genes associated with increased risk of bowel cancer.
Everyman | Everywoman Plus Tumour-Associated Markers £857 – With this health test, you can get unrivalled insights on your overall health, in addition to several tumour markers associated with bowel, ovarian, prostate, liver, and pancreatic cancer from a simple blood test.